BioCentury
ARTICLE | Finance

IPO Watch

French companies Deinove and Neovacs update terms for Euronext IPOs

April 12, 2010 7:00 AM UTC

Two French companies updated their IPO terms last week, as bioprocessing play Deinove and autoimmune and inflammation company Neovacs S.A. aim to complete their deals over the next two weeks.

Deinove is using deinococci bacteria to develop technologies to make biofuels and antibiotics, which are in discovery. It is seeking to raise about €12 million ($16.2 million) through the sale of 1.4 million shares at €7.50-€9.16 in an IPO on Euronext Paris...